![Barbara Duncan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barbara Duncan
Directeur/Membre du Conseil chez
HALOZYME THERAPEUTICS, INC.
Fortune : 2 M $ au 31/05/2026
Profil
Ms. Barbara G.
Duncan is an Independent Director at Halozyme Therapeutics, Inc., an Independent Director at Atea Pharmaceuticals, Inc. and an Independent Director at Ovid Therapeutics, Inc. She is on the Board of Directors at Halozyme Therapeutics, Inc., Halozyme, Inc., Versanis Bio, Inc., Atea Pharmaceuticals, Inc. and Ovid Therapeutics, Inc. Ms. Duncan was previously employed as a Chairman by Fusion Pharmaceuticals, Inc., an Independent Director by Immunomedics, Inc., an Independent Director by ObsEva SA, an Independent Non-Executive Director by Adaptimmune Therapeutics Plc, a Non-Executive Director by Adaptimmune Ltd., an Independent Director by Jounce Therapeutics, Inc., an Independent Director by Aevi Genomic Medicine, Inc., a Chief Financial Officer, Secretary & Treasurer by Intercept Pharmaceuticals, Inc., a Chief Executive & Financial Officer, Director by DOV Pharmaceutical, Inc., a Vice President-Corporate Finance Division by Lehman Brothers, Inc., a Director-Corporate Finance by SBC Warburg Dillon Read Corporate Finance AG, an International Auditor by PepsiCo, Inc., and a Senior Accountant by D&T Partners LLP.
She also served on the board at Innoviva, Inc. and Edgemont Pharmaceuticals LLC.
She received her undergraduate degree from Louisiana State University and an MBA from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/05/2026 | 19 919 ( 0,02% ) | 1 M $ | 31/05/2026 | |
| 24/04/2026 | 92 350 ( 0,12% ) | 431 275 $ | 31/05/2026 | |
| 17/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Barbara Duncan
| Sociétés | Poste | Début |
|---|---|---|
| OVID THERAPEUTICS INC. | Directeur/Membre du Conseil | 14/06/2017 |
| ATEA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/10/2020 |
| HALOZYME THERAPEUTICS, INC. | Directeur/Membre du Conseil | 03/02/2023 |
Versanis Bio, Inc.
 Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Directeur/Membre du Conseil | 20/07/2022 |
Halozyme, Inc.
 Halozyme, Inc. BiotechnologyHealth Technology Part of Halozyme Therapeutics, Inc., Halozyme, Inc. is a company based in San Diego, CA. | Directeur/Membre du Conseil | 01/02/2023 |
Anciens postes connus de Barbara Duncan
| Sociétés | Poste | Fin |
|---|---|---|
| FUSN PHAR | Président | 04/06/2024 |
| ADAPTIMMUNE THERAPEUTICS PLC | Directeur/Membre du Conseil | 01/06/2023 |
| JOUNCE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 03/05/2023 |
| OBSEVA SA | Directeur/Membre du Conseil | 28/05/2021 |
| ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Barbara Duncan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
86
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
PepsiCo, Inc.
 PepsiCo, Inc. Food: Specialty/CandyConsumer Non-Durables Makes, markets, distributes and sells beverages & convenient food products | Consumer Non-Durables |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
DOV Pharmaceutical, Inc.
 DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops novel drugs | Commercial Services |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Edgemont Pharmaceuticals LLC
 Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Health Technology |
Atea Pharmaceuticals, Inc.
 Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
Ovid Therapeutics, Inc.
 Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
SBC Warburg Dillon Read Corporate Finance AG
 SBC Warburg Dillon Read Corporate Finance AG Investment Banks/BrokersFinance Provides investment banking services | Finance |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Louisiana State University
 Louisiana State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aevi Genomic Medicine, Inc.
 Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of treatments for auto-immune pediatric disease | Health Technology |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Focuses on the use of T cell therapy to treat cancer and infectious diseases | Health Services |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
Halozyme, Inc.
Halozyme, Inc. BiotechnologyHealth Technology Part of Halozyme Therapeutics, Inc., Halozyme, Inc. is a company based in San Diego, CA. | Health Technology |
ObsEva SA
 ObsEva SA Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments to increase women's reproductivity | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
